Solesence (NASDAQ:SLSN) Issues Earnings Results

Key Points

• Solesence (NASDAQ:SLSN) reported $0.04 earnings per share with revenue of $20.36 million for the quarter, and achieved a return on equity of 34.68%.
• The stock traded down 19.0% to $2.78 after the earnings release, with a significant decrease from its 50-day moving average price of $4.11.
• Wall Street Zen downgraded Solesence from a "hold" to a "sell" rating following the earnings announcement, indicating a bearish outlook.

Solesence (NASDAQ:SLSN - Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.04 earnings per share (EPS) for the quarter, Zacks reports. The business had revenue of $20.36 million for the quarter. Solesence had a net margin of 8.13% and a return on equity of 34.68%.

Solesence Price Performance

Solesence stock traded up $0.09 during mid-day trading on Wednesday, hitting $3.04. The stock had a trading volume of 87,457 shares, compared to its average volume of 121,110. The stock has a market cap of $214.27 million, a price-to-earnings ratio of 43.43 and a beta of 0.87. The company has a 50 day moving average of $4.06. Solesence has a one year low of $1.21 and a one year high of $16.56.

Insider Buying and Selling

In other Solesence news, COO Kevin Cureton sold 38,807 shares of the business's stock in a transaction on Friday, June 6th. The shares were sold at an average price of $3.80, for a total value of $147,466.60. Following the sale, the chief operating officer owned 192,212 shares in the company, valued at $730,405.60. The trade was a 16.80% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 4.80% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen upgraded shares of Solesence from a "sell" rating to a "hold" rating in a report on Sunday.

About Solesence

Nanophase Technologies Corporation provides engineered materials, formulation development, and commercial manufacturing with an integrated family of technologies in the United States. It offers surface engineered zinc oxide and titanium dioxide for sunscreens and personal care products; fully formulated cosmetics, sun care, and skin care under the Solésence brand name; and advanced materials products, such as architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and various surface finishing technologies applications.